Regeneron Pharmaceuticals (REGN)

Financing Cash Flow

-$2.34B

Quarterly · Period ending: · USD

REGN logo

REGN Financing Cash Flow

Latest reported-$2.34B
REGN Quarterly Cash from Financing ($0.00 → -$2.34B)
High-resolution chart · PNG

REGN financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-2,344,800,000
-802,200,000
-780,100,000
-717,900,000
-1,128,200,000
-1,089,200,000
-1,135,500,000
-634,000,000
-478,100,000
47,100,000
-446,100,000
-407,300,000
-614,200,000
-322,500,000
-247,600,000
-725,000,000
-101,100,000
64,700,000
-906,600,000
385,400,000
-118,200,000
-366,400,000
-305,300,000
612,000,000
-2,612,800,000
335,600,000
-345,700,000
-11,000,000
-15,300,000
119,900,000
-83,034,000
3,714,000
-11,207,000
13,427,000
-210,535,000
-8,196,000
133,519,000
60,812,000
-491,679,000
28,675,000
-31,195,000
-206,192,000
-4,008,000
-345,649,000
-3,535,000
90,396,000
-252,763,000
5,166,000
-80,012,000
108,954,000
105,564,000
3,533,000
-43,481,000
11,523,000
-73,010,000
-1,809,000
-5,077,000
-17,750,000
361,440,000
-279,000
10,051,000
13,037,000
182,759,000
1,613,000
2,719,000
56,215,000
22,328,000
2,148,000
5,849,000
1,038,000
-115,719,000
1,324,000
-80,366,000
1,903,000
314,229,000
347,000
2,866,000
1,958,000
180,125,000
1,070,000
787,000
3,416,000
2,959,000
90,000
2,000
1,030,000
819,000
-808,000
329,000
4,101,000
4,588,000
49,523,000
5,576,000
48,497,000
594,000
-48,000
120,000
1,057,000
191,280,000
398,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.